Magnetic drug targeting - Biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment

Journal of Drug Targeting

Volumn 11, Issue 3, 2003, Pages 139-149

  Alexiou, Christoph ^a   Jurgons, Roland ^a   Schmid, Roswitha J ^a   Bergemann, Christian ^b   Henke, Julia ^c   Erhardt, Wolf ^c   Huenges, Ernst ^d   Parak, Fritz ^d  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Chemicell   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ferrofluids; Intraarterial cancer treatment; Magnetic drug targeting; Mitoxantrone distribution; Nanotechnology

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; FERRIC HYDROXIDE; IODINE 123; IRON 59; IRON DERIVATIVE; IRON OXIDE; MAGNETITE; MITOXANTRONE; NANOPARTICLE; POLYMER; STARCH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BODY FLUID; CANCER CHEMOTHERAPY; CANCER TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TARGETING; ELECTROMAGNETIC FIELD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; ISOTOPE LABELING; MAGNETIC FIELD; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; SQUAMOUS CELL CARCINOMA; TUMOR; URINALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; IODINE RADIOISOTOPES; IRON RADIOISOTOPES; MAGNETICS; MITOXANTRONE; NANOTECHNOLOGY; NEOPLASMS, EXPERIMENTAL; PARTICLE SIZE; RABBITS;

EID: 0141989515     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1061186031000150791     Document Type: Article

References (42)

1. Alberts, D.S., Peng, Y.M., Leigh, S., Davis, T.P. and Woodward, D.L. (1985) "Disposition of mitoxantrone in cancer patients", Cancer Res. 45, 1879-1884.
2. Alexiou, C., Arnold, W., Klein, R.J., Parak, F.G., Hulin, P., Bergemann, C., Erhardt, W., Wagenpfeil, S. and Lübbe, A.S. (2000) "Locoregional cancer treatment with Magnetic Drug Targeting", Cancer Res. 60, 6641-6648.
3. Alexiou, Ch., Schmidt, A., Klein, R., Hulin, P., Bergemann, Ch. and Arnold, W. (2002) "Magnetic drug targeting: biodistribution and dependency on magnetic field strength", JMMM 252, 363-366.
4. Alksne, J.F., Fingerhut, A. and Rand, R. (1966) "Magnetically controlled metallic thrombosis of intracranial aneurysms", Surgery 60, 212-218.
5. Batra, V.K., Morrison, J.A., Woodward, D.L., Siverd, N.S. and Yacobi, A. (1986) "Pharmacokinetics of mitoxantrone in man and laboratory animals", Drug Metab. Rev. 17, 311-329.
6. Bergemann, C. (1996) German Patent Application No. 19624426.9.
7. Berger, H., Baethge, I., Rudolphi, A., Boos, K., Stäbler, A., Reiser, M. and Seidel, D. (1996) "Transcatheter chemoembolisation of hepatocellular carcinoma: a study of the pharmacokinetics of epirubicin with Lipiodol® or starch microspheres as embolizing agent", Reg. Cancer Treat. 9, 181-185.
8. Bistner, S.I., Ford, R.B., Raffe and MR., eds (1995) Kirk and Bistner's Handbook of Veterinarian Procedures and Emergency Treatment (W.B. Saunders Co., Philadelphia) p 907.
9. Canal, P., Attal, M., Chatelut, E., Guichard, S., Huguet, F., Muller, C., Schlaifer, D., Laurent, G., Houin, G. and Bugat, R. (1993) "Plasma cellular pharmacokinetics of mitoxantrone in a high-dose chemotherapeutic regimen for refractory lymphomas", Cancer Res. 53, 4850-4854.
10. Claudio, F., Cacace, F., Comella, G., Coucourde, F., Claudio, L., Bevilacqua, A.M. and Toma, S. (1990) "Intraarterial chemotherapy through carotid transposition in advanced head and neck cancer", Cancer 65, 1465-1471.
11. Dufour, P, Bergerat, J.P., Barats, J.C., Giron, C., Duclos, B., Dellenbach, P., Ritter, J., Renaud, R., Audhuy, B. and Oberling, F. (1994) "Intraperitoneal mitoxantrone as consolidation treatment of patients with ovarian carcinoma in pathologic complete remission", Cancer 73, 1865-1869.
12. Eckardt, A., Kelber, A. and Pytlik, C. (1995) "Palliative intraarterial chemotherapy with carboplatin (CBDCA) and 5-FU in unresectable advanced (stage III-IV) head and neck cancer using implantable port sytems", Eur. J. Surg. Oncol. 21, 486-489.
13. Eichfeld, U., Gläser, A., Schneider, G., Kraus, J., Pauer, H.J. and Schwarz, J. (1993) "Die regionale zytostatische Extremitätenperfusion bei Patienten mit malignem Melanom und Weichteilsarkom-therapeutische Anwendungen und Ergebnisse", Zentralbl. Chir. 118, 63-68.
14. Farrés, M.T., de Baere, T., Lagrange, C., Ramirez, L., Rougier, P., Munck, J.N. and Roche, A. (1998) "Percutaneous mitoxantrone injection for primary and secondary liver tumors: preliminary results", Cardiovasc. Intervetional Radiol. 21, 399-403.
15. Gerlowski, L.E. and Jain, R.K. (1986) "Microvascular permeability of normal and neoplastic tissues", Microvasc. Res. 31, 288-299.
16. Gupta, P.K. and Hung, C.T. (1994) "Magnetically controlled targeted chemotherapy", In: Willmott, N. and Daly, J., eds, Microspheres and Regional Cancer Therapy (CRC Press, Boca Raton, FL), pp 71-116.
17. Hilal, S.K., Michelsen, W.J., Driller, J. and Leonard, E. (1974) "Magnetically guided devices for vascular exploration and treatment", Radiology 113, 529-534.
18. Ishii, E., Eguchi, H., Matsuzaki, A., Koga, H., Yanai, F, Kuroda, H., Kawakami, K., Ayukawa, H., Akiyoshi, K., Kamizono, J., Tamai, Y., Kinukawa, N. and Okamura, J. (2001) "Outcome of acute lymphoblastic leukemia in children with AL90 regimen: Impact of response to treatment and sex difference on prognostic factors", Med. Pediatr. Oncol. 37, 10-19.
19. Kidd, F.G. and Rous, P. (1940) "A transplantable rabbit-carcinoma originating in a virus-induced papilloma. and containing the virus in masked or altered form", J. Exp. Med. 71, 813-838.
20. Kramer, P.A. (1974) "Albumin microspheres vehicles for archiving specificity in drug delivery", J. Pharm. Sci. 63, 1646-1647.
21. Langer, R. (2001) "Drugs on target", Science 293, 58-59.
22. Lorenz, M. and Rossion, I. (1995) "Adjuvante und palliative regionale Therapie von Lebermetastasen kolorektaler Tumoren", Dtsch. Med. Wochenschr. 120, 690-697.
23. Lübbe, A.S., Bergemann, Ch., Huhnt, W., Fricke, T., Riess, H., Brock, J.W. and Huhn, D. (1996a) "Preclinical experiences with magnetic drug targeting: tolerance and efficacy", Cancer Res. 56, 4694-4701.
24. Lübbe, A.S., Bergemann, Ch., Riess, H., Schriever, E, Reichardt, P., Possinger, K., Matthias, M., Dorken, B., Herrmann, F, Gurtler, R., Hohenberger, P., Haas, N., Sohr, R., Sander, B., Lemke, A.-J., Ohlendorf, D., Huhnt, W. and Huhn, D. (1996b) "Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors", Cancer Res. 56, 4686-4693.
25. Morris, R.M., Poore, G.A., Howard, D.P. and Sefranka, J.A. (1984) "Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in yoshida-bearing rats", In: Davis, S.S., Illum, L., McVie, J.G. and Tomlinson, E., eds, Microspheres and Drug Therapy. Pharmaceutical, Immunological and Medical Aspects (Elsevier, New York), pp 439-440.
26. Oettle, H., Kratschmer, B., Löffel, J., Vogl, T.J. and Riess, H. (1998) "Regionale Chemotherapie von Lebermetastasen bei kolorektalen Karzinomen", Onkologe 4, 67-78.
27. Preiß, J., Link, K.H. and Schmoll, E. (1999) "Regionale Chemotherapie", In: Schmoll, H.J., Höffken, K. and Possinger, K., eds, Kompendium internistische Onkologie (Springer Verlag, Berlin) pp 1755-1763.
28. Rahman, Y., Cerny, E.A., Tallaksen, S.L., Wright, B.J., Nance, S.O. and Thompson, J.F. (1974) "Liposomes-encapsulated actinomycin D: potential in cancer chemotherapy", Proc. Soc. Exp. Biol. Med. 146, 1173-1176.
29. Ramirez, L.H., Zhao, Z., Rougier, P., Bognel, C., Dzodic, R., Vassal, G., Ardouin, P., Gouyette, A. and Munck, J.N. (1996) "Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbits", Cancer Chemother. Pharmacol. 37, 371-376.
30. Rassweiler, J. (1994) Neoadjuvant chemotherapy of invasive bladder cancer", Urologe A 33, 576-581.
31. Robbins, K.T., Vicario, D., Seagren, S., Weisman, R., Pelliteri, P., Kerber, C., Orloff, L., Los, G. and Howell, S.B. (1994) "A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer", Am. J. Surg, 168, 419-442.
32. Roboz, J., Paciucci, P.A., Silides, D., Greaves, J. and Holland, J.F. (1984) "Detection and quantification of mitoxantrone in human organs", Cancer Chemother. Pharmacol. 13, 67-68.
33. Romeis, B. (1998) Mikroskopische Technik (Urban und Schwarzenberg, München Wien, Baltimore), 399-400, pp 235-236.
34. Samant, S., Robbins, K.T., Kumar, P., Ma, J.Z., Vieira, F. and Hanchett, C. (2001) "Bone or cartilage invasion by advanced head and neck cancer: intraarterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation", Arch. Otolaryngol. Head Neck Surg. 127, 1451-1456.
35. v. Scheel, J. and Kastenbauer, E. (1981) "Intraarterielle Cisplatin-Therapie beim adenoid-zystischen Karzinom", HNO 29, 308-311.
36. Stewart, D.J., Green, R.M., Mikhael, N.Z., Montpetit, V., Thibault, M. and Maroun, J.A. (1986) "Human autopsy tissue concentrations of mitoxantrone", Cancer Treat. Rep. 70, 1255-1261.
37. Walter, K.A., Tamargo, R.J., Olivi, A., Burger, P.C. and Brem, H. (1995) "Intratumoral chemotherapy", Neurosurgery 37, 1129-1145.
38. Wenig, B.L., Werner, J.A., Castro, D.J., Sridhar, K.S., Garewal, H.S., Kehrl, W., Pluzanska, A., Arndt, O., Costantino, P.D., Mills, G.M., Dunphy, F.R., Orenberg, E.K. and Leavitt, R.D. (2002) "The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck", Arch. Otolaryngol. Head Neck Surg. 128, 880-885.
39. Widder, K.J., Senyei, A.E. and Scarpelli, D.G. (1978) "Magnetic microspheres: a model system for site specific drug delivery in vivo", Proc. Soc. Exp. Biol. Med. 158, 141-146.
40. Widder, K.J., Senyei, A.E. and Ranney, D.F. (1979) "Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents", In: Gavattini, S., Goldin, A., Howking, F., Kopin, I.J. and Schnitzer, R.J., eds, Advances in Pharmacology and Chemotherapy (New York, NY, Academic Press), pp 213-239.
41. Widder, K.J., Morris, R.M., Poore, G.A., Howard, D.P. and Senyei, A.E. (1983) "Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in yoshida sarcoma bearing rats", Eur Cancer Clin. Oncol. 19, 135-199.
42. Zamboglou, N., Wurm, R., Pape, H., Schnabel, T., Kuhn, F., Streffer, C. and Schmitt, G. (1991) "Simultaneous radiotherapy and intratumoral instillation of mitoxantrone in locoregional recurrence of head and neck carcinoma", Reg. Cancer Treat. 4, 79-84.